Lumen Bio
PrivateLast Round
Series C
Extension
Oct 8, 2025
Total Funding Raised
$56M
Company Overview
Lumen Bioscience is a biotechnology company that develops orally delivered biologic drugs for highly prevalent diseases using a proprietary spirulina-based biomanufacturing platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumen Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Lumen Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Oct 8, 2025 | ||||
| Grant | Jan 4, 2023 | ||||
| Grant | Jan 4, 2023 | ||||
| Grant | Jan 27, 2021 | ||||
| Grant | Sep 24, 2020 | ||||
Series A | Dec 5, 2017 |
Lumen Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Gates Foundation | Grant, Series C Extension |
| Bioeconomy Capital | Series A, Grant |
| WestRiver Group | Grant, Series C Extension |
| Columbia Pacific Advisors | Grant |
| Medical Technology Enterprise Consortium | Grant |
| Department of Energy | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 28, 2025
Monthly visitors grew 204% MoM.
- Jan 4, 2023
Secured $4M in grant funding.
Lumen Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumen Bio's valuation, stock price, and market status.